[1]席 颖,张腾飞,余军林,等.中性粒细胞百分比、淋巴细胞百分比对肺腺癌EGFR-TKI靶向治疗预后的预测价值[J].郑州大学学报(医学版),2018,(05):619-622.[doi:10.13705/j.jssn.1671-6825.2018.01.122]
 XI Ying,ZHANG Tengfei,YU Junlin,et al.Prognosis assessment value of neutrophil percentage and lymphocyte percentage for lung adenocarcinoma patients with EGFR-TKI targeted therapy[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(05):619-622.[doi:10.13705/j.jssn.1671-6825.2018.01.122]
点击复制

中性粒细胞百分比、淋巴细胞百分比对肺腺癌EGFR-TKI靶向治疗预后的预测价值()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2018年05期
页码:
619-622
栏目:
应用研究
出版日期:
2018-09-20

文章信息/Info

Title:
Prognosis assessment value of neutrophil percentage and lymphocyte percentage for lung adenocarcinoma patients with EGFR-TKI targeted therapy
作者:
席 颖张腾飞余军林耿一萌杜雅冰崔 抗马 望
郑州大学第一附属医院肿瘤科 郑州 450052
Author(s):
XI Ying ZHANG Tengfei YU Junlin GENG Yimeng DU Yabing CUI Kang MA Wang
Department of Oncology, the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052
关键词:
表皮生长因子受体-酪氨酸激酶抑制剂 肺腺癌 中性粒细胞百分比 淋巴细胞百分比 靶向治疗
Keywords:
EGFR-TKI lung adenocarcinoma neutrophil percentage lymphocyte percentage targeted therapy
分类号:
R734.2
DOI:
10.13705/j.jssn.1671-6825.2018.01.122
摘要:
目的:探讨中性粒细胞百分比、淋巴细胞百分比对肺腺癌表皮生长因子受体-酪氨酸激酶抑制剂(EGFR-TKI)靶向治疗预后的预测价值。方法:收集162例接受EGFR-TKI靶向治疗的肺腺癌患者的治疗资料和随访资料,采用Cox回归模型分析预后的影响因素。结果:162例中,18、19、20、21位点突变分别有4、81、11和66例。治疗前162例患者中性粒细胞百分比(62.90±12.58)%,其中在正常范围130例,降低8例,升高24例; 淋巴细胞百分比(25.39±10.89)%,其中在正常范围102例,降低48例,升高12例。Cox回归分析结果显示,以EGFR基因突变类型为分层因素,在调整年龄、性别因素后,治疗前淋巴细胞百分比升高可降低肺腺癌EGFR-TKI靶向治疗的不良预后风险(HR=0.934,95%CI 为0.884~0.987)。结论:淋巴细胞百分比可能是一个重要的肺癌EGFR-TKI靶向治疗预后预测因子。
Abstract:
Aim: To investigate the prognosis assessment value of neutrophil percentage and lymphocyte percentage for lung adenocarcinoma patients with EGFR-TKI targeted therapy.Methods:The data of 162 lung adenocarcinoma patients treated with EGFR-TKI were analyzed retrospectively.The relationship between neutrophil percentage,lymphocyte percentage and prognosis was assessed by Cox regression analysis.Results:Out of the 162 cases,there were 4,81,11 and 66 mutation cases at positions 18,19,20 and 21,respectively.Before treatment,the neutrophil percentage in 162 patients was(62.90±12.58)%,in which 130 cases were normal,8 were decreased,and 24 were increased; the lymphocyte percentage was(25.39±10.89)%,in which 102 cases were normal,48 were decreased,and 11 were increased.Cox regression analysis showed that,with EGFR gene mutation as a stratification factor,after adjusting age and gender,the increase of pretreatment lymphocyte percentage could reduce the adverse prognosis risk(HR=0.934,95%CI was 0.884 to 0.987).Conclusion: Lymphocyte percentage may be an important biomarker for the prognosis assessment of lung adenocarcinoma patients with EGFR-TKI targeted therapy.

参考文献/References:

[1] HIRSCH FR,SCAGLIOTTI GV,MULSHINE JL,et al.Lung cancer: current therapies and new targeted treatments[J].Lancet,2017,389(10066):299
[2] WEI XL,ZHANG DS,HE MM,et al.The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma[J].Tumour Biol,2016,37(2):1879
[3] SMYTH MJ,DUNN GP,SCHREIBER RD.Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity[J].Adv Immunol,2006,90:1
[4] CHO O,OH YT,CHUN M,et al.Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer[J].Tumour Biol,2016,37(1):971
[5] RASHTAK S,RUAN X,DRULINER BR,et al.Peripheral neutrophil to lymphocyte ratio improves prognostication in colon cancer[J].Clin Colorectal Cancer,2017,16(2):115
[6] KOMURA N,MABUCHI S,YOKOI E,et al.Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review[J].Int J Clin Oncol,2018,23(1):104
[7] MEHRAZIN R,UZZO RG,KUTIKOV A,et al.Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma[J].Urologic Oncol,2015,33(9):388
[8] WILD AT,YE X,ELLSWORTH SG,et al.The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma[J].Am J Clin Oncol,2015,38(3):259
[9] PAUKEN KE,WHERRY EJ.Overcoming T cell exhaustion in infection and cancer[J].Trends Immunol,2015,36(4):265
[10]WADA M,TSUCHIKAWA T,KYOGOKU N,et al.Clinical implications of CD4+CD25+Foxp3+regulatory T cell frequencies after CHP-MAGE-A4 cancer vaccination[J].Anticancer Res,2018,38(3):1435
[11]STOTZ M,PICHLER M,ABSENGER G,et al.The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage Ⅲ colon cancer[J].Br J Cancer,2014,110(2):435
[12]YAO Y,YUAN D,LIU H,et al.Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy[J].Cancer Immunol Immunother,2013,62(3):471
[13]HE JR,SHEN GP,REN ZF,et al.Pretreatment levels of peripheral neutrophils and lymphocytes as Independent prognostic factors in patients with nasopharyngeal carcinoma[J].Head Neck,2012,34(12):1769
[14]LI C,WEN TF,YAN LN,et al.Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation[J].PLoS One,2013,8(8):e72235
[15]MATIC’ IZ,KOLUNDIJA B,DAMJANOVIC’ A,et al.Peripheral white blood cell subsets in metastatic colorectal cancer patients treated with cetuximab: the potential clinical relevance[J].Front Immunol,2017,8:1886
[16]FENG F,SUN L,ZHENG G,et al.Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer[J].Oncotarget,2017,8(3):5281
[17]BECHT E,GIRALDO NA,DIEU-NOSJEAN MC,et al.Cancer immune contexture and immunotherapy[J].Curr Opin Immunol,2016,39:7
[18]管超.非小细胞肺癌EGFR基因不同突变类型的预后及临床特征的回顾性研究[D].沈阳:中国医科大学,2014.

相似文献/References:

[1]王晓慧),刁长英),谢艺林),等.THBS1表达上调对肺腺癌细胞增殖、凋亡和细胞周期的影响[J].郑州大学学报(医学版),2018,(06):730.[doi:10.13705/j.issn.1671-6825.2018.04.088]
 WANG Xiaohui),DIAO Changying),XIE Yilin),et al.Effects of up-regulating THBS1 expression on proliferation, apoptosis and cell cycle of lung adenocarcinoma cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2018,(05):730.[doi:10.13705/j.issn.1671-6825.2018.04.088]
[2]刁长英),王晓慧),谢艺林),等.上调THBS1蛋白的表达对肺腺癌H1975细胞迁移能力的影响[J].郑州大学学报(医学版),2019,(03):382.[doi:10.13705/j.issn.1671-6825.2018.05.071]
 DIAO Changying),WANG Xiaohui),XIE Yilin),et al.Effects of up-regulation of THBS1 on migration of lung adenocarcinoma H1975 cells[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(05):382.[doi:10.13705/j.issn.1671-6825.2018.05.071]

备注/Memo

备注/Memo:
【基金项目】国家自然科学基金面上项目(31570917)
【作者简介】马望,通信作者,男,1977年11月生,博士,教授,主任医师,研究方向:癌症的综合治疗及中西医结合治疗,E-mail:doctormawang@126.com
更新日期/Last Update: 2018-09-20